An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild/moderate cases of COVID-19
Strub-Wourgaft et al., ANTICOV
https://c19early.org/strubwourgaftlpv.html